Vascular inflammation plays a key role in the pathogenesis and progression of atherosclerosis, a main complication of diabetes. The present study investigated whether an aqueous extract of Portulaca oleracea (AP) prevents the TNF-α-induced vascular inflammatory process in the human umbilical vein endothelial cell (HUVEC). The stimulation of TNF-α induced overexpression of adhesion molecules affects vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1 and E-selectin for example. However, AP significantly suppressed TNF-α-induced over-expression of these adhesion molecules in a dose-dependent manner. In addition, pretreatment with AP dose-dependently reduced an increase of the adhesion of HL-60 cells to TNF-α-induced HUVEC. Furthermore, we observed that stimulation of TNF-α significantly increased intracellular reactive oxygen species (ROS) production. However, pretreatment with AP markedly blocked TNF-α-induced ROS production in a dose-dependent manner. The western blot and immunofluorescence analysis showed that AP inhibited the translocation of p65 NF-κB to the nucleus. In addition, AP suppressed the TNF-α-induced degradation of IκB-α and attenuated the TNF-α-induced NF-κB binding. AP also effectively reduced TNF-α-induced mRNA expressions of monocyte chemoattractant protein (MCP)-1 and interleukin (IL)-8 in a dose-dependent manner. Taken together, AP prevents the vascular inflammatory process through the inhibition of intracellular ROS production and NF-κB activation as well as the reduction of adhesion molecule expression in TNF-α-induced HUVEC. These results suggested that AP might have a potential therapeutic effect by inhibiting the vascular inflammation process in vascular diseases such as atherosclerosis.
References
[1]
Libby, P.; Sukhova, G.; Lee, R.T.; Galis, Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol 1995, 2, 9–12.
[2]
Ross, R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med 1999, 340, 115–126.
[3]
Quagliaro, L.; Piconi, L.; Assaloni, R.; da Ros, R.; Maier, A.; Zuodar, G.; Ceriello, A. Intermittent HG enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: The distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005, 183, 259–267.
Ahmad, M.; Zhang, Y.; Parpharalambus, C.; Alexander, R.W. Role of isoprenylcysteine carboxyl methyltransferase in tumor necrosis factor-α stimulation of expression of vascular cell adhesion molecule-1 in ECs. Arterioscler. Thromb. Vasc. Biol 2001, 22, 759–764.
[7]
Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K. Inhibition of aldose reductase attenuates TNF-α-induced expression of adhesion molecules in endothelial cells. FASEB J 2004, 18, 1209–1218.
[8]
Lockyer, J.M.; Colladay, J.S.; Alprin-Lea, W.L.; Hammond, T.; Buda, A.J. Inhibition of nuclear factor κB-mediated adhesion molecule expression in human endothelial cells. Circ. Res 1998, 82, 314–320.
[9]
Lee, Y.J.; Kang, D.G.; Kim, J.S.; Lee, H.S. Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells. Vascul. Pharmacol 2008, 48, 38–46.
[10]
Kim, H.J.; Park, K.G.; Yoo, E.K.; Kim, Y.H.; Kim, Y.N.; Kim, H.S.; Kim, H.T.; Park, J.Y.; Lee, K.U.; Jang, W.G.; et al. Effects of PGC-1α on TNF-α-induced MCP-1 and VCAM-1 expression and NF-κB activation in human aortic smooth muscle and endothelial cells. Antioxid. Redox. Signal 2007, 9, 301–307.
[11]
Harrison, D.; Griendling, K.K.; Landmesser, U.; Hornig, B.; Drexler, H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol 2003, 91, 7A–11A.
[12]
Chen, C.C.; Chow, M.P.; Huang, W.C.; Lin, Y.C.; Chang, Y.J. Flavonoids inhibit tumor necrosis factor-α-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-κB: Structure-activity relationships. Mol. Pharmacol 2004, 66, 683–693.
[13]
Yoon, J.J.; Lee, Y.J.; Kim, J.S.; Kang, D.G.; Lee, H.S. Protective role of betulinic acid on TNF-α-induced cell adhesion molecules in vascular endothelial cells. Biochem. Biophys. Res. Commun 2010, 391, 96–101.
[14]
Mohanapriya, S.; Senthilkumar, P.; Sivakumar, S.; Dineshkumar, M.; Subbhuraam, C.V. Effects of copper sulfate and copper nitrate in aquatic medium on the restoration potential and accumulation of copper in stem cuttings of the terrestrial medicinal plant, Portulaca oleracea Linn. Environ. Monit. Assess 2006, 121, 233–244.
[15]
Rasheed, A.N.; Afifi, F.U.; Shaedah, M.; Taha, M.O. Investigation of the active constituents of Portulaca oleracea L. (Portulacaceae) growing in Jordan. Pak. J. Pharm. Sci 2004, 17, 37–45.
[16]
Zhang, X.J.; Ji, Y.B.; Qu, Z.h.Y.; Xia, J.C.h.; Wang, L. Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chin. J. Microecol 2002, 14, 277–280.
[17]
Chan, K.; Islam, M.W.; Kamil, M.; Radhakrishnan, R.; Zakaria, M.N.M.; Habibullah, M.; Attas, A. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J. Ethnopharmacol 2000, 73, 445–451.
[18]
Parry, O.; Marks, J.A.; Okwuasaba, F. The skeletal muscle relaxant action of Portulaca oleracea: Role of potassium ions. J. Ethnopharmacol 1993, 40, 187–194.
[19]
Rasheed, A.N.; Afifi, F.U.; Disi, A.M. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmacol 2003, 88, 131–136.
[20]
Awad, N.E. Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L. Bull. Fac. Pharm 1994, 32, 137–142.
[21]
Sakai, N.; Inada, K.; Okamoto, M.; Shizuri, Y.; Fukuyama, Y.; Portuloside, A. a monoterpene glucoside from Portulaca oleracea. Phytochemistry 1996, 42, 1625–1628.
[22]
Liu, L.; Howe, P.; Zhou, Y.F.; Xu, Z.Q.; Hocart, C.; Zhan, R. Fatty acids and beta-carotene in australian purslane (Portulaca oleracea) varieties. J. Chromatogr. A 2000, 893, 207–213.
[23]
Che, W.; Lerner-Marmarosh, N.; Huang, Q.; Osawa, M.; Ohta, S.; Yoshizumi, M. Insulin-like growth factor-1 enhances inflammatory responses in ECs: Role of Gab1 and MEKK3 in TNF-α-induced c-Jun and NF-κB activation and adhesion molecule expression. Circ. Rec 2002, 90, 1222–1230.
[24]
Abou-Raya, A.; Abou-Raya, S. Inflammation: A pivotal link between autoimmune diseases and atherosclerosis. Autoimmun. Rev 2006, 5, 331–337.
Hajra, L.; Evans, A.I.; Chen, M.; Hyduk, S.J.; Collins, T.; Cybulsky, M.I. The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. USA 2000, 97, 9052–9057.
[34]
Kumar, S.; Sharma, A.; Madan, B.; Singhal, V.; Ghosh, B. Isoliquiritigenin inhibits IκB kinase activity and ROS generation to block TNF-α induced expression of cell adhesion molecules on human endothelial cells. Biochem. Pharmacol 2007, 73, 1602–1612.
[35]
Bonizzi, G.; Piette, J.; Merville, M.P.; Bours, V. Cell type-specific role for reactive oxygen species in nuclear factor-κB activation by interleukin-1. Biochem. Pharmacol 2000, 59, 7–11.
[36]
Schoonbroodt, S.; Piette, J. Oxidative stress interference with the nuclear factor-κB activation pathways. Biochem. Pharmacol 2000, 60, 1075–1083.
[37]
Calixto, J.B.; Campos, M.M.; Otuki, M.F.; Santos, A.R. Antiinflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004, 70, 93–103.
[38]
Hayashi, K.; Takahata, H.; Kitagawa, N. N-acetylcysteine inhibited nuclear factor-κB expression and the intimal hyperplasia in rat carotid arterial injury. Neurol. Res 2001, 23, 731–738.
[39]
Lee, A.S.; Lee, Y.J.; Lee, S.M.; Yoon, J.J.; Kim, J.S.; Kang, D.G.; Lee, H.S. Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice. Evid. Based Complement Alternat Med 2012, 2012, doi:10.1155/2012/741824.
[40]
Radhakrishnan, R.; Zakaria, M.N.; Islam, M.W.; Chen, H.B.; Kamil, M.; Chan, K. Neuropharmacological actions of Portulaca oleracea L v. sativa (Hawk). J. Ethnopharmacol 2001, 76, 171–176.
[41]
Cai, Y.; Luo, Q.; Sun, M.; Corke, H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 2004, 74, 2157–2184.
[42]
Gao, D.; Li, Q.; Fan, Y. Hypoglycemic effects and mechanisms of Portulaca oleracea L. in alloxan-induced diabetic rats. J. Med. Plants Res 2010, 4, 1996–2003.
[43]
Wang, C.Q.; Yang, G.Q. Betacyanins from Portulaca oleracea L. ameliorate cognition deficits and attenuate oxidative damage induced by D-galactose in the brains of senescent mice. Phytomedicine 2010, 17, 527–532.
[44]
Zhao, R.; Li, Q.; Xiao, B. Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats. Yakugaku Zassh 2006, 125, 981–988.
[45]
Singab, A.N.; El-Beshbishy, H.A.; Yonekawa, M.; Nomura, T.; Fukai, T. Hypoglycemic effect of Egyptian Morus alba root bark extract: Effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J. Ethnopharmacol 2005, 100, 333–338.
[46]
Manduteanu, I.; Voinea, M.; Antohe, F.; Dragomir, E.; Capraru, M.; Radulescu, L.; Simionescu, M. Effect of enoxaparin on high glucose-induced activation of endothelial cells. Eur. J. Pharmacol 2003, 477, 269–276.
[47]
De Clerck, L.S.; Bridts, C.H.; Mertens, A.M.; Moens, M.M.; Stevens, W.J. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods 1994, 172, 115–124.
